Dr. Aage Møller is known internationally for his innovative research on sensory systems and neural plasticity and for developing methods for reducing the risk of neurological deficits in neurosurgical operations. His work has helped establish UT Dallas as a leader in tinnitus-related research. Dr. Møller’s lengthy research career has focused on four primary areas. The basicfunction of the ear, sound transmission in the middle ear and cochlea, the neural code of complex sounds and neural plasticity. He eventually moved on to research in humans aimed at studying disorders of the year and the nervous system, such as tinnitus. He began his research career at the famed Karolinska Institut in Sweden. In 1978 he was invited to join the University of Pittsburgh. There he did innovative research in the area of neurosurgery and intraoperative neurophysiology; he developed methods for reducing the risks of serious neurological deficits after neurosurgical operations. He was one of the founders of a new specialty; intraoperative neurophysiological monitoring and he did innovative research that lead to better understanding of several neurological diseases. When Dr. Møller joined UT Dallas 1997, he became interested in abnormalities in the nervous system function among individuals with autism. He developed teaching programs in the biology of pain; sensory systems, neuroplasticity and he established the first university program in teaching IONM in a graduate program. During his time at UT Dallas, he was named the university’s “President’s Teaching Excellence Award,” won Teacher of the Year for the School of Behavioral and Brain Sciences, and was named distinguished lecturer in Cognition and Neuroscience. Dr. Møller earned his PhD in medical science at the Karolinska Institut in Stockholm, Sweden.
Timothy L Vollmer, MD, is Professor of Neurology at the University of Colorado Denver Anschutz Medical Campus, Medical Director of the Rocky Mountain MS Center, and Co-Director of the Rocky Mountain Center for MS Care and Research at the Anschutz Medical Campus, all located in Aurora, CO. He earned his MD from Stanford University School of Medicine in Stanford, CA and completed his internship at the Yale New Haven Hospital in New Haven, CT. He conducted his residency in neurology and was later named Chief Resident at Stanford University Hospital. In addition, he completed a postdoctoral fellowship in neuroimmunology at University Hospital in Stanford, CA. He is a fellow of the American Academy of Neurology and is a current member of several professional societies including the American Association of Immunology, the Society of Neuroscience, and the Consortium of MS Centers, where he is Director of the NARCOMS Project. With close to 100 publications in peer-reviewed journals, his research interests include MS comorbidities, emerging therapies, and the immunopathophysiology of MS.
Dr. Herndon graduated from the University of Tennessee Medical School in 1958. He did his internship and residency at Wayne State University followed by fellowships at the Montreal Neurological Institute and in the Dept. of Anatomy at Harvard Medical School. He has served on the faculty of Stanford University, Johns Hopkins University, the University of Rochester and University of Mississippi. He was the founding editor of the International Journal of MS care, past president of the Consortium of MS Centers. He has published more than 150 peer reviewed papers and edited 5 books. He remains active in teaching and research.
Moses Rodriguez is Professor of Neurology and Immunology and is recipient of the highest award at Mayo Clinic – Distinguished Investigator Award. Dr. Rodriguez earned his M.D. degree at Northwestern University (1977). After neurology residency at Mayo (1977-1981), he was an NIH post-doctoral fellow in neuropathology at University of California, San Diego, and immunology and virology at Scripps Research Institute (1981-1983). Dr. Rodriguez holds 18 U.S. patents and has authored 421 peer- reviewed papers. He directed the M.D. /Ph.D. MSTP Program at Mayo Medical School, the National MS Society Center of Excellence and the Mayo Center for Multiple Sclerosis and Central Nervous System Demyelinating Diseases Research and Therapeutics.
Dr. Kilgard trained in biochemistry and genetics at UC Berkely and in neuroscience at UC San Francisco. He is the Margaret Fonde Jonnson Professor and the Associate Director of the Texas Biomedical Device Center. He has published more than 90 paper in peer reviewed journals, including Nature, Science, Neuron, and Stroke. Dr. Kilgard holds 23 U.S. patents and regularly reviews for the NIH. His work is currently supported by DARPA, NINDS, NIDCD, Wings for Life Spinal Cord Research Foundation, and the W.W. Caruth, Jr. Foundation Fund at Communities Foundation of Texas.
Dr. Christadoss has been studying the immunopathogenesis of myasthenia gravis (MG) for more than 3 decades. At present he is studying the complement RNAi in the therapy of animal model of MG and plans to perform translational studies in human MG in collaboration with Immune Globe, LLC and Duke University. The complement RNAi therapy will be applied in the animal model of rheumatoid arthritis as well. He is also developing biomarkers for MG. In addition he is studying the immunopathogenesis of MuSK induced MG and developing a new model of MG induced by LRP4 autoimmunity.
Dr. Giulio Maria Pasinetti, The Saunders Family Chair and Professor of Neurology, received an M.D. from the Milan University School of Medicine and a Ph.D. from the University of Milan. He is currently the Program Director of the NIH funded Mount Sinai Center for Molecular Integrative Neuroresilience and the Chief of the Brain Institute Center of Excellence for Novel Approaches to Neurodiagnostics and Neurotherapeutics. He is also a Professor of Psychiatry, of Neuroscience, and of Geriatrics and Adult Development. Dr. Pasinetti is the recipient of several academic awards including the prestigious Zenith and Temple awards from the Alzheimer's Association. Most recently, Dr. Pasinetti was awarded ''The Faculty Council Award'' for academic excellence at Mount Sinai School of Medicine and "The Charles Dana Alliance for Brain Research Award" from Dana Foundation, recognizing productivity and worldwide leadership in his field of expertise, which further emphasizes his standing as an academic role model.
Dr Maria Anagnostouli graduated from the Medical School of National and Kapodistrian University of Athens (NKUA), Greece and fulfilled the 4-year residency at the 1st Dept. of Neurology, NKUA, at Aeginition University Hospital. She obtained her Ph.D, from NKUA-Medical School, 1st Dept. of Neurology, in cooperation with the Department of Radioisotopes/Radiodiagnostic Products, Institute of Nuclear and Radiological Sciences & Technology, Energy and Safety (INRaSTES), National Center for Scientific Research (NCSR) “Demokritos” , Greece (Determination of biotin in the Cerebrospinal Fluid and serum of patients with various neurological disorders, Degree: Excellent). She performed post-doctoral education/training, at Massachusetts General Hospital (MGH), Boston-USA, at Paul Terasaki’s/One-Lambda Laboratory, at UCLA, Los Angeles-USA, for the “HLA DNA TECHNICAL WORKSHOP”, at Brigham and Women’s Hospital, of Harvard University, for children and adults with multiple sclerosis, in 2014. She established and autonomously run the Research Immunogenetics Laboratory of the 1st Dept. of Neurology, NKUA, at Aeginition Hospital, where she works as Assistant Professor of Neurology at the Demyelinating Diseases Clinic. She is member of several national and international societies covering the fields of neurology, multiple sclerosis, neuroimmunology and immunogenetics (EFI) and stress biology. Recently, she joined the International Paediatric Multiple Sclerosis Working Group (IPMSSG), LONDON-2016 Meeting and Society. She is author of more than 40 peer-reviewed papers, and more than 150 published peer-reviewed congress abstracts. She serves as reviewer of many national and international medical journals. She wrote as co-author a chapter on Neuroinflammation, in a textbook (2016) and as an editor, an interdisciplinary book on Neuroaesthetics (2014). She initiated and was the President of the Organizing Committee of 5 Congresses/Symposia, entitled “Dialogues of Hellenic Neuroscientists” from 2011 to-date, mainly on Pediatric and Adult Multiple Sclerosis.
Head and Neck surgery
Dr. Kiminobu Sugaya is a professor of medicine in Burnett School of Biomedical Science, College of Medicine, University of Central Florida (UCF) since 2004. He is a Director of Multidisciplinary Neuroscience Alliance of UCF and a Chair of Central Florida Chapter of Society for Neuroscience. He moved from Japan to Mayo Clinic, US as a post doc. in 1992 when he was a lecturer in Science University of Tokyo and he was promoted to an associate consultant in 1994. Then he moved to University of Illinois at Chicago as an assistant professor in 1997 and got promotied to an associate professor in 2002. He has been conducting stem cell researches to treat neurodegenerative diseases by the adult stem cells. He recently received National Honor Plaque of Panama for exceptional contribution to neuroscience based on his study on stem cell therapies for neurodegenerative diseases from the President of Panama. His publication regarding improvement of memory in the aged animal by stem cell transplantation was reported Washington Post, BBC, NBC, ABC and other media in all over the world. Dr. Sugaya is also a founder and chair of Progenicyte, which is a biotech company holding his 67 patent licenses. Among those are a revolutionary process of creating iPS (induced pluripotent stem) cells from a patient's own cells and a novel pharmacological approach to increase endogenous stem cells. With Dr. Sugaya's proprietary technologies covering all aspects of stem cell manipulations, Progenicyte is launching services to include: modified stem cell banking and a commercial product to increase cellular regeneration which fights against aging. Certain to be at the forefront of stem cell innovation.
Professor Viroj Wiwanitkit is a medical professor and Asian Scholar. He is presently a visiting University Professor, Hainan Medical University, China. He has more than 950 international journal publications and 150 international textbook publications. He is editor in chief and editorial board of more than 40 journals. He has ever been invited to be keynote speakers of many international conferences. He is the Thai scientists with the most number of publications. He is a guest lecturer of many universities.
Multiple Sclerosis,Neurological Disorders
Dr. Nina Riggins, MD is a Doctor primarily located in San Francisco, CA. She has 16 years of experience. Her specialties include Neurology and Psychiatry. Dr. Riggins is affiliated with University of California San Francisco Medical Center at Parnassus and University of California San Francisco Medical Center at Parnassus.
Multiple Sclerosis,Neurological Disorders
A Pragatheswaran Pragathy is a Senior medical director in public health care foundation. He has completed Doctorate in hospital management european continental university. Special trainee in general medicine pg diploma in Ent diseases securing university first rank winning a gold medal fellow of indian medical academy. Mba in health care and hospital administration. From south californian university. Currently honorary medical director in guru cancer institute And Medical Director Of A Hospital For Chronic Head Ache And Ent/Head And Neck Diseases
Head and Neck surgery
Dr. Pappolla's training includes medical residencies and fellowships training in Neurology and Pain Medicine (Anesthesia based) and also in Clinical Pathology, Anatomic Pathology, and Neuropathology. This training required 10 additional years of formal medical education (following graduation from Medical School) all pursued in programs accredited by the American Board of Medical Specialties, considered the "gold-standard" in physician education in the United States. Dr. Pappolla holds active board-certifications in 5 disciplines of Medicine (Pain Management, Neurology, Anatomic Pathology, Clinical Pathology and Neuropathology). He has also been serving the public at large for over 20 years as a consultant for the NIH (National Institutes of Health) and a full Professor or Faculty at several of the most prestigious medical schools in the USA (LSU New Orleans, Mount Sinai Medical School in New York City, University of Texas at Houston) where he taught Neurosciences to medical students and medical residents for over 20 years. Dr. Pappolla has also served as Director of Pathology and Laboratory Medicine at an Academic Department of Veterans Affairs Medical Center in the New York region in the 90's and as Chairman of Neurology and Director of Neurosciences in one of the largest tertiary care centers in Mississippi, till his practice was disrupted by hurricane Katrina. He returned to Houston, TX where he relocated his clinical practice. His scientific work includes more than 100 publications and book chapters in neuroscience. Dr. Pappolla's research is cited in more than 2000 textbooks worldwide (for independent analysis, please view some of the research by clicking here: http://books.google.com/books?q=pappolla ). Citations of his landmark peer reviewed papers range between 300 and 900 with an H index of 43. For more information on the clinical practice, please visit www.SMPSclinic.com
Pain Management, Neurologist
Dr. Denis Gris has started his scientific career with the Master's and Ph.D. in Neuroscience at Dr. Lynn Weaver's laboratory at the University of Western Ontario. He studied the role of inflammation in spinal cord injury. He discovered that the influx of neutrophils is detrimental for recovering after spinal cord injury. Using anti CD11d antibody as a treatment, he demonstrated that animals recovered faster and better after the treatment. Also, he showed that sever spinal cord injury results in massive inflammatory reactions throughout the body leading to syndrome similar to multiple organ dysfunction syndrome. Dr. Denis Gris continued his education in Dr. Jenny P-Y Ting's laboratory as a post doctoral fellow at the University of North Carolina at Chapel Hill. There he studied in detail mechanism of activation of innate and adoptive immune responses. In collaboration with Dr. Wen, Dr. Eitas, Dr. Allen, and other members of the laboratory, Dr. Gris studied inflammation during obesity which leads to insulin resistance; innate and adoptive responses during multiple sclerosis. In summary, his role in this laboratory was to define the role of novel family of immuno regulatory proteins (NLRs) in different human diseases. Currently, Dr. Denis Gris is a member of Immunology Program at the University of Sherbrooke and he is studying neuro-immune interactions during healthy state and disease.
Behavioral neuroscience, Neuro-immunology, and Autoimmune Diseases